According to the 2021 WHO Classification of Tumors of the Central Nervous System, IDH-mutant astrocytoma was molecularly characterized by IDH mutations without 1p19q co-deletion and was classified as WHO grades 2–4 [1]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).